< Back to previous page

Publication

Frequency and prognostic impact of ALK amplifications and mutations in the European Neuroblastoma Study Group (SIOPEN) high-risk neuroblastoma trial (HR-NBL1)

Journal Contribution - Journal Article

Journal: JOURNAL OF CLINICAL ONCOLOGY
ISSN: 1527-7755
Issue: 30
Volume: 39
Pages: 3377 - 3390
Publication year:2021
Accessibility:Open